Loading company details...
Beta
Latest Form 4 (Sep 29, 2026): Thomas Edward Schoenherr (CEO, Diagnostics): Sale of 10,281 shares, $873.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Thomas Edward Schoenherr, CEO, Diagnostics | Sale | 10,281 | $873.9K |
| Sep 24, 2026 | Eric P. Lefkofsky, CEO and Chairman | Sale | 7,394 | $566.2K |
| Sep 19, 2026 | Eric P. Lefkofsky, CEO and Chairman | Sale | 52,558 | $4.23M |
| Sep 19, 2026 | Ryan M. Bartolucci, Chief Accounting Officer | Sale | 7,062 | $529.6K |
| Sep 19, 2026 | Andrew Polovin, EVP, Chief Legal Officer | Sale | 2,951 | $221.3K |
| Sep 19, 2026 | Ryan Fukushima, CEO, Data | Sale | 700 | $49.0K |
| Sep 1, 2026 | Nadja West | Sale | 3,000 | $207.0K |
| Aug 28, 2026 | Eric P. Lefkofsky, CEO and Chairman | Sale | 11,167 | $779.8K |
| Aug 28, 2026 | Eric P. Lefkofsky, CEO and Chairman | Sale | 760 | $48.7K |
| Aug 25, 2026 | Thomas Edward Schoenherr, CEO, Diagnostics | Sale | 2,694 | $188.6K |